22.	Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income

										Company and
	Consolidated			Physician			Unrestricted			Restricted
For the six months ended June 30, 2016	Total			Groups			Subsidiaries			Subsidiaries⁽¹⁾
Patient service operating revenues	$	5,048,392		$	175,933		$	—		$	4,872,459
Less: Provision for uncollectible accounts		(220,633	)		(5,830	)		—			(214,803	)
Net patient service operating revenues		4,827,759			170,103			—			4,657,656
Capitated revenues		1,784,873			802,431			—			982,442
Other revenues		686,155			29,970			—			656,185
Total net operating revenues		7,298,787			1,002,504			—			6,296,283
Operating expenses		6,604,828			998,744			(28	)		5,606,112
Operating income		693,959			3,760			28			690,171
Debt expense, including refinancing charges		(205,778	)		(8,405	)		—			(197,373	)
Other income		6,191			258			—			5,933
Income tax expense		261,710			9,504			11			252,195
Net income (loss)		232,662			(13,891	)		17			246,536
Less: Net income attributable to noncontrolling interests		(81,846	)		—			—			(81,846	)
Net income (loss) attributable to DaVita HealthCare Partners Inc.	$	150,816		$	(13,891	)	$	17		$	164,690

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income

									Company and
	Consolidated			Physician			Unrestricted		Restricted
For the six months ended June 30, 2016	Total			Groups			Subsidiaries		Subsidiaries⁽¹⁾
Net income (loss)	$	232,662		$	(13,891	)	$	17	$	246,536
Other comprehensive loss		(61	)		—			—		(61	)
Total comprehensive income (loss)		232,601			(13,891	)		17		246,475
Less: comprehensive income attributable to the noncontrolling interests		(81,995	)		—			—		(81,995	)
Comprehensive income (loss) attributable to DaVita HealthCare Partners Inc.	$	150,606		$	(13,891	)	$	17	$	164,480

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets

							Company and
	Consolidated		Physician		Unrestricted		Restricted
As of June 30, 2016	Total		Groups		Subsidiaries		Subsidiaries⁽¹⁾
Cash and cash equivalents	$	1,283,416	$	81,620	$	—	$	1,201,796
Accounts receivable, net		1,875,403		205,112		—		1,670,291
Other current assets		1,337,398		18,155		—		1,319,243
Total current assets		4,496,217		304,887		—		4,191,330
Property and equipment, net		2,972,407		1,502		—		2,970,905
Amortizable intangibles, net		1,631,001		5,393		—		1,625,608
Other long-term assets		231,048		74,090		2,796		154,162
Goodwill		9,360,957		16,234		—		9,344,723
Total assets	$	18,691,630	$	402,106	$	2,796	$	18,286,728
Current liabilities	$	2,645,662	$	225,660	$	—	$	2,420,002
Payables to parent		—		70,352		2,796		(73,148	)
Long-term debt and other long-term liabilities		10,150,362		51,585		—		10,098,777
Noncontrolling interests subject to put provisions		936,903		—		—		936,903
Total DaVita HealthCare Partners Inc. shareholders’ equity		4,746,054		54,509		—		4,691,545
Noncontrolling interests not subject to put provisions		212,649		—		—		212,649
Shareholders’ equity		4,958,703		54,509		—		4,904,194
Total liabilities and shareholder’s equity	$	18,691,630	$	402,106	$	2,796	$	18,286,728

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows

										Company and
	Consolidated			Physician			Unrestricted			Restricted
For the six months ended June 30, 2016	Total			Groups			Subsidiaries			Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income (loss)	$	232,662		$	(13,891	)	$	17		$	246,536
Changes in operating and intercompany assets and liabilities and non-cash items included in net income		712,977			144,876			(17	)		568,118
Net cash provided by operating activities		945,639			130,985			—			814,654
Cash flows from investing activities:
Additions of property and equipment		(358,627	)		(350	)		—			(358,277	)
Acquisitions and divestitures, net		(473,314	)		—			—			(473,314	)
Proceeds from discontinued operations		17,393			—			—			17,393
Investments and other items		56,319			(1,465	)		—			57,784
Net cash used in investing activities		(758,229	)		(1,815	)		—			(756,414	)
Cash flows from financing activities:
Long-term debt		(61,233	)		(4	)		—			(61,229	)
Intercompany		—			(135,791	)		—			135,791
Other items		(342,321	)		—			—			(342,321	)
Net cash used in by financing activities		(403,554	)		(135,795	)		—			(267,759	)
Effect of exchange rate changes on cash		444			—			—			444
Net decrease in cash		(215,700	)		(6,625	)		—			(209,075	)
Cash and cash equivalents at beginning of period		1,499,116			88,245			—			1,410,871
Cash and cash equivalents at end of period	$	1,283,416		$	81,620		$	—		$	1,201,796

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.